Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old rats

Neurobiology of Aging

Volumn 29, Issue 12, 2008, Pages 1894-1901

  Marchalant, Yannick ^a   Cerbai, Francesca ^a   Brothers, Holly M ^a   Wenk, Gary L ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Activated microglia; Aging; Cannabinoid receptors; Inflammation; Spatial memory

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID 1 RECEPTOR;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; CELL ACTIVATION; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; MALE; MEMORY DISORDER; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; RAT; SPATIAL MEMORY;

AGING; ANIMALS; BRAIN; ENCEPHALITIS; LIPOPOLYSACCHARIDES; MALE; MEMORY; RATS; RATS, INBRED F344; RECEPTORS, CANNABINOID;

EID: 53649083332     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2007.04.028     Document Type: Article

References (44)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B., Finch C.E., Frautschy S., Griffin W.S.T., Hampel H., Landreth G., McGeer P.L., Mrak R., MacKenzie I., O'Banion K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., and Wyss-Coray A. Inflammation in Alzheimer's disease. Neurobiol. Aging 21 (2000) 383-421
2. Begg M., Pacher P., Batkai S., Osei-Hyiaman D., Offertaler L., Mo F.M., Liu J., and Kunos G. Evidence for novel cannabinoid receptors. Pharmacol. Ther. 2 (2005) 133-145
3. Benito C., Nunez E., Tolon R.M., Carrier E.J., Rabano A., Hillard C.J., and Romero J. Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. J. Neurosci. 23 (2003) 11136-11141
4. Berrendero F., Romero J., Garcia-Gil L., Suarez I., De la Cruz P., Ramos J.A., and Fernandez-Ruiz J.J. Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats. Biochim. Biophys. Acta 1407 (1998) 205-214
5. Castellano C., Rossi-Arnaud C., Cestari V., and Costanzi M. Cannabinoids and memory: animal studies. Curr. Drug Targets CNS Neurol. Disord. 2 (2003) 389-402
6. Curran N.M., Griffin B.D., O'Toole D., Brady K.J., Fitzgerald S.N., and Moynagh P.N. The synthetic cannabinoid R(+)WIN 55,212-2 inhibits the interleukin-1 signaling pathway in human astrocytes in a cannabinoid receptor-independent manner. J. Biol. Chem. 280 (2005) 35797-35806
7. Facchinetti F., Del Giudice E., Furegato S., Passarotto M., and Leon A. Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide. Glia 41 (2003) 161-168
8. 2+/calmodulin-dependent protein kinase II in long-term potentiation. J. Neurosci. 21 (2001) 7053-7062
9. Gong J.P., Onaivi E.S., Ishiguro H., Liu Q.R., Tagliaferro P.A., Brusco A., and Uhl G.R. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res. 1071 (2006) 10-23
10. Hampson A.J., and Grimaldi M. Cannabinoid receptor activation and elevated cyclic AMP reduce glutamate neurotoxicity. Eur. J. Neurosci. 13 (2001) 1529-1536
11. Hauss-Wegrzyniak B., Dobrzanski P., Stoehr J.D., and Wenk G.L. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Res. 780 (1998) 294-303
12. Hauss-Wegrzyniak B., Vraniak P., and Wenk G.L. The effects of a novel NSAID upon chronic neuroinflammation are age dependent. Neurobiol. Aging 20 (1999) 305-313
13. Katona I., Sperlagh B., Sik A., Kafalvi A., Vizi E.S., Mackie K., and Freund T.F. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci. 9 (1999) 4544-4558
14. Katona I., Urban G.M., Wallace M., Ledent C., Jung K.M., Piomelli D., Mackie K., and Freund T.F. Molecular composition of the endocannabinoid system at glutamatergic synapses. J. Neurosci. 26 (2006) 5628-5637
15. Kim S.U., and de Vellis J. Microglia in health and disease. J. Neurosci. Res. 81 (2005) 302-313
16. Klein T.W., Newton C., Larsen K., Lu L., Perkins I., Nong L., and Friedman H. The cannabinoid system and immune modulation. J. Leuk. Biol. 74 (2003) 486-496
17. Klein T.W. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat. Rev. Immunol. 5 (2005) 400-411
18. Kuhn S.A., van Landeghem F.K., Zacharias R., Farber K., Rappert A., Pavlovic S., Hoffmann A., Nolte C., and Kettenmann H. Microglia express GABA(B) receptors to modulate interleukin release. Mol. Cell Neurosci. 25 (2004) 312-322
19. Marchalant Y., Rosi S., and Wenk G.L. Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation. Neuroscience 144 (2007) 1516-1522
20. Marsicano G., Goodenough S., Monory K., Hermann H., Eder M., Cannich A., Azad S.C., Cascio M.G., Gutiérrez S.O., van de Stelt M., López-Rodriguez M.L., Casanova E., Schu{combining double acute accent}tz G., Zieglgänsberger W., Di Marzo V., Behl C., and Lutz B. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302 (2003) 84-88
21. Munro S., Thomas K.L., and Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365 (1993) 61-65
22. Nadel L., and Land C. Memory traces revisited. Nat. Rev. Neurosci. 1 (2000) 209-212
23. Nagayama T., Sinor A.D., Simon R.P., Chen J., Graham S.H., Jin K., and Greenberg D.A. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J. Neurosci. 19 (1999) 2987-2995
24. Onaivi E.S., Ishigurao H., Gong J., Patel S., Perchuk A., Meozzi P., Myers L., Mora Z., Tagliaferro P., Gardner E., Brusco A., Akinshola B.E., Liu Q., Hope B., Iwasaki S., Arinami T., Teasenfitz L., and Uhl G.R. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann. NYAS 1074 (2006) 514-536
25. Parmentier-Batteur S., Jin K., Mao X.O., Xie L., and Greenberg D.A. Increased severity of stroke in CB1 cannabinoid receptor knock-out mice. J. Neurosci. 22 (2002) 9771-9775
26. Perry V.H., Matyszak M.K., and Fearn S. Altered antigen expression of microglia in the aged rodent CNS. Glia 7 (1993) 60-67
27. Pertwee R.G. Pharmacological actions of cannabinoids. Handbook Exp. Pharmacol. 168 (2005) 1-51
28. Piomelli D. The molecular logic of endocannabinoid signaling. Nat. Rev. Neurosci. 4 (2003) 873-884
29. Pryce G., Ahmed Z., Hankey D.J., Jackson S.J., Croxford J.L., Pocock J.M., Ledent C., Petzold A., Thompson A.J., Giovannoni G., Cuzner M.L., and Baker D. Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain 126 (2003) 2191-2202
30. Ramirez B.G., Blazquez C., Gomez del Pulgar T., Guzman M., and de Ceballos M.L. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J. Neurosci. 25 (2005) 1904-1913
31. Rosi S., Ramirez-Amaya V., Vazdarjanova A., Worley P.F., Barnes C.A., and Wenk G.L. Neuroinflammation alters the hippocampal pattern of behaviorally induced Arc expression. J. Neurosci. 25 (2005) 723-731
32. Rosi S., Vazdarjanova A., Ramirez-Amaya V., Worley P.F., Barnes C.A., and Wenk G.L. Memantine protects against LPS-induced neuroinflammation, restores behaviorally-induced gene expression and spatial learning in the rat. Neuroscience 142 (2006) 1303-1315
33. Sheng W.S., Hu S., Min X., Cabral G.A., Lokensgard J.R., and Peterson P.K. Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1β-stimulated human Astrocytes. Glia 49 (2005) 211-219
34. 1 receptor. Biochem. Pharmacol. 69 (2005) 169-178
35. Stella N. Cannabinoid signaling in glial cells. Glia 48 (2004) 267-277
36. Streit W.J. Microglial senescence: does the brain's immune system have an expiration date?. Trends Neurosci. 29 (2006) 506-510
37. Takahashi K.A., and Castillo P.E. The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus. Neuroscience 139 (2006) 795-802
38. Thompson S.E., Ayman G., Woodhall G.L., and Jones R.S. Depression of glutamate and GABA release by presynaptic GABA(B) receptors in the entorhinal cortex in normal and chronically epileptic rats. Neurosignals 5 (2007) 202-215
39. Tsou K., Brown S., Sanudo-Pena M.C., Mackie K., and Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83 (1998) 393-411
40. Van Sickle M.D., Duncan M., Kingsley P.J., Mouihate A., Urbani P., Mackie K., Stella N., Makriyannis A., Piomelli D., Davison J.S., Marnett L.J., Di Marzo V., Pittman Q.J., Patel K.D., and Sharkey K.A. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310 (2005) 329-332
41. Waksman Y., Olson J., Carlisle S.J., and Cabral G.A. The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells. J. Pharmacol. Exp. Ther. 288 (1999) 1357-1366
42. Walter L., Franklin A., Witting A., Moller T., and Stella N. Astrocytes in culture produce anandamide and other acylethanolamides. J. Biol. Chem. 277 (2002) 20869-20876
43. Wenk G.L., and Barnes C.A. Regional changes in the hippocampal density of AMPA and NMDA receptors across the lifespan of the rat. Brain Res. 885 (2000) 1-5
44. Wenk G.L., Parson C., and Danysz W. Potential role of NMDA receptors as executors of neurodegeneration resulting from diverse insults-focus on memantine. Behav. Pharmacol. 17 (2006) 411-424